KALV - Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Benjamin L Palleiko	462.6K	$12.49M	-
Other	Christopher Yea	223.5K	$6.03M	-
Other	Paul K. Audhya	142.5K	$3.85M	-
Other	Nicole Sweeny	51.4K	$1.39M	-
CFO	Brian Piekos	18.1K	$490.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 20, 2024	Edward P. Feener72	Chief Scientific Officer	Sale+OE10b5-1	8,088	$11.76	$95,151.28	-10.0%	+3.0%	+3.0%
May 20, 2024	Paul K. Audhya	Chief Medical Officer	Sale+OE	13,175	$11.76	$154,997.29	-15.8%	+3.0%	+3.0%
May 20, 2024	Benjamin L Palleiko46	Chief Executive Officer	Sale+OE	21,959	$11.76	$258,336.66	-9.2%	+3.0%	+3.0%
Feb 20, 2024	Christopher Yea53	Chief Development Officer	Sale+OE	12,053	$14.11	$170,124.48	-14.2%	-13.9%	-22.4%
Feb 20, 2024	Benjamin L Palleiko46	CFO, Cbo	Sale+OE	22,802	$14.11	$321,845.67	-10.9%	-13.9%	-22.4%
Feb 20, 2024	Paul K. Audhya	Chief Medical Officer	Sale+OE	14,295	$14.12	$201,773.93	-21.3%	-13.9%	-22.4%
Feb 20, 2024	Thomas Andrew Crockett72	CEO	Sale+OE	24,888	$14.11	$351,289.14	-10.5%	-13.9%	-22.4%
Feb 20, 2024	Edward P. Feener72	Chief Scientific Officer	Sale+OE10b5-1	28,288	$14.07	$397,929.01	-31.3%	-13.9%	-22.4%
Feb 14, 2024	Benjamin L Palleiko46	CFO, Cbo	Sell	40,855	$15.01	$613,204.95	-20.4%	-13.3%	-33.8%
Feb 14, 2024	Thomas Andrew Crockett72	CEO	Sell	58,356	$15.01	$875,882.71	-24.3%	-13.3%	-33.8%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC